About Pro Medicus Limited (PME)
Pro Medicus Limited is a Health Information Services company operating in the Healthcare sector.
PME trades on the Australian Securities Exchange and is classified as a large-cap stock .
Key Statistics
- Current Price
- A$196.20
- Market Cap
- A$20.50B
- 52-Week High
- A$272.85
- 52-Week Low
- A$107.75
- Sector
- Healthcare
- Industry
- Health Information Services
A$1,000 Invested in Pro Medicus Limited (PME)
How much would A$1,000 invested in PME be worth today?
What would A$1,000 invested in PME 1 year ago be worth today?
A A$1,000 investment in Pro Medicus Limited (PME) in 2025 would be worth A$748 as of November 2026, representing a -25.2% total return.
What would A$1,000 invested in PME 3 years ago be worth today?
A A$1,000 investment in Pro Medicus Limited (PME) in 2023 would be worth A$2,659 as of November 2026, representing a +165.9% total return.
What would A$1,000 invested in PME 5 years ago be worth today?
A A$1,000 investment in Pro Medicus Limited (PME) in 2021 would be worth A$3,753 as of November 2026, representing a +275.3% total return.
What would A$1,000 invested in PME 10 years ago be worth today?
A A$1,000 investment in Pro Medicus Limited (PME) in 2016 would be worth A$41,375 as of November 2026, representing a +4037.5% total return.
What would A$1,000 invested in PME at IPO be worth today?
A A$1,000 investment in Pro Medicus Limited (PME) at IPO would be worth A$274,615 as of November 2026, representing a +27361.5% total return.
Monthly Returns Heatmap
Over the past 26+ years (312 months), Pro Medicus Limited (PME) has averaged a monthly return of +2.65% with a median return of +1.14%. The stock had 170 positive months (54%) and 136 negative months (44%). The best month in PME's history was June 2026 with a +53.8% return, while the worst was February 2026 at -29.2%. Historically, November tends to be the strongest month (averaging +7.5%), and February the weakest (-3.1%).
PME's longest winning streak was 10 consecutive months of gains, while its longest losing streak was 4 consecutive months of losses. The best full year was 2015 with a cumulative return of +126.9%, and the worst was 2011 at -47.7%.
Annual Returns
Over 26 years of trading history, Pro Medicus Limited (PME) has delivered an average annual return of +35.62% with a median return of +23.17%. The compound annual growth rate (CAGR) is +23.45%. The stock posted gains in 15 years (58%) and losses in 11 years (42%).
PME's best year was 2015 with a +210.88% gain, while the worst was 2011 at -50.88%. The longest streak of consecutive positive years was 10, and the longest losing streak was 4 years. PME achieved double-digit gains (10%+) in 15 years. It suffered double-digit losses in 9 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -10.73% | A$219.79 | A$196.20 |
| 2025 | -11.52% | A$248.42 | A$219.79 |
| 2024 | +161.84% | A$94.87 | A$248.42 |
| 2023 | +74.19% | A$54.46 | A$94.87 |
| 2022 | -11.11% | A$61.27 | A$54.46 |
| 2021 | +83.31% | A$33.43 | A$61.27 |
| 2020 | +53.66% | A$21.75 | A$33.43 |
| 2019 | +106.53% | A$10.53 | A$21.75 |
| 2018 | +25.55% | A$8.39 | A$10.53 |
| 2017 | +83.18% | A$4.58 | A$8.39 |
| 2016 | +44.36% | A$3.17 | A$4.58 |
| 2015 | +210.88% | A$1.02 | A$3.17 |
| 2014 | +59.40% | A$0.64 | A$1.02 |
| 2013 | +75.53% | A$0.36 | A$0.64 |
| 2012 | +55.09% | A$0.24 | A$0.36 |
| 2011 | -50.88% | A$0.48 | A$0.24 |
| 2010 | -35.51% | A$0.74 | A$0.48 |
| 2009 | -2.66% | A$0.76 | A$0.74 |
| 2008 | -26.60% | A$1.04 | A$0.76 |
| 2007 | +11.46% | A$0.93 | A$1.04 |
| 2006 | -7.77% | A$1.01 | A$0.93 |
| 2005 | +20.79% | A$0.84 | A$1.01 |
| 2004 | +57.82% | A$0.53 | A$0.84 |
| 2003 | -14.77% | A$0.62 | A$0.53 |
| 2002 | -15.35% | A$0.73 | A$0.62 |
| 2001 | -10.62% | A$0.82 | A$0.73 |
Frequently Asked Questions: PME
What sector is PME in? ▼
PME operates in the Healthcare sector, specifically in the Health Information Services industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has PME performed historically? ▼
Over 26 years of trading history, PME has posted gains in 15 years (58% of the time). The best year was 2015 with a +210.9% return. Past performance does not guarantee future results.
How can I invest in PME? ▼
You can invest in PME through any brokerage account that offers access to the Australian Securities Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold PME.
Last updated: 11/1/2026